Inventor · disambiguated record
Joelle Le
Also filed as: LE JOELLE
27 granted patents·17 pending applications·311 citations·filing 2004–2024
96Inventor score
Files withGLAXO GROUP LTD15HAMBLIN JULIE NICOLE9BALDWIN IAN ROBERT7GLAXOSMITHKLINE IP DEV LTD3UNIV YALE3
Top patents by PatentIndex Score
44 records- 0197US8586583B2CompoundsHAMBLIN JULIE NICOLE·Filed 2012·Granted Nov 19, 2013·52 cites·7 claims
- 0292US8163743B24-carboxamide indazole derivatives useful as inhibitors of PI3-kinasesBALDWIN IAN ROBERT·Filed 2009·Granted Apr 24, 2012·43 cites·11 claims
- 0391US10730862B2Compounds and methods for the enhanced degradation of targeted proteins and other polypeptides by an E3 ubiquitin ligaseUNIV YALE·Filed 2013·Granted Aug 4, 2020·15 cites·14 claims
- 0490US10383879B2CompoundsGLAXO GROUP LTD·Filed 2019·Granted Aug 20, 2019·4 cites·8 claims
- 0589US9540318B2Sulfonamide compounds and their use in the modulation retinoid-related orphan receptorGLAXO GROUP LTD·Filed 2015·Granted Jan 10, 2017·3 cites·15 claims
- 0689US9353098B2Polymorphs and saltsGLAXO GROUP LTD·Filed 2015·Granted May 31, 2016·4 cites·3 claims
- 0789US8609657B2CompoundsHAMBLIN JULIE NICOLE·Filed 2012·Granted Dec 17, 2013·6 cites·11 claims
- 0888US9326987B2Indazole derivatives for use in the treatment of influenza virus infectionHAMBLIN JULIE NICOLE·Filed 2011·Granted May 3, 2016·5 cites·3 claims
- 0988US8575162B2CompoundsHAMBLIN JULIE NICOLE·Filed 2010·Granted Nov 5, 2013·6 cites·7 claims
- 1088US8084457B2Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinasesCHOIDAS AXEL·Filed 2004·Granted Dec 27, 2011·76 cites·25 claims
- 1187US8586590B2CompoundsHAMBLIN JULIE NICOLE·Filed 2012·Granted Nov 19, 2013·5 cites·11 claims
- 1287US8580797B2CompoundsHAMBLIN JULIE NICOLE·Filed 2010·Granted Nov 12, 2013·5 cites·8 claims
- 1386US9150508B2Sulfonamide compounds and their use in the modulation retinoid-related orphan receptorGLAXO GROUP LTD·Filed 2012·Granted Oct 6, 2015·4 cites·18 claims
- 1486US9102668B2Polymorphs and saltsGLAXOSMITHKLINE IP DEV LTD·Filed 2014·Granted Aug 11, 2015·3 cites·4 claims
- 1585US7557110B2Pyrazolo[1,5-A] pyrimidine derivativesTEIJIN PHARMA LTD·Filed 2004·Granted Jul 7, 2009·44 cites·53 claims
- 1684US9428452B2CompoundsGLAXO GROUP LTD·Filed 2013·Granted Aug 30, 2016·8 cites·39 claims
- 1780US8735390B2Polymorphs and saltsHAMBLIN JULIE NICOLE·Filed 2011·Granted May 27, 2014·5 cites·3 claims
- 1878US9242972B2CompoundsGLAXO GROUP LTD·Filed 2013·Granted Jan 26, 2016·5 cites·28 claims
- 1977US8536169B2CompoundsBALDWIN IAN ROBERT·Filed 2009·Granted Sep 17, 2013·4 cites·9 claims
- 2076US8993576B26-(1H-indol-4-yl)-4-(5-{[4-1-methylethyl)-1-piperazinyl]methyl}-1,3-oxazol-2-yl)-1H-indazole hemi succinate salt, polymorphs and pharmaceutical compositions thereofHAMBLIN JULIE NICOLE·Filed 2011·Granted Mar 31, 2015·3 cites·4 claims
- 2175US7667036B2Pyrazolo[1,5-a]pyrimidine derivativesTEIJIN PHARMA LTD·Filed 2005·Granted Feb 23, 2010·3 cites·31 claims
- 2274US10624898B2CompoundsGLAXO GROUP LTD·Filed 2019·Granted Apr 21, 2020·0 cites·8 claims
- 2374US2024317729A1Compounds & Methods for the Enhanced Degradation of Targeted Proteins & Other Polypeptides by an E3 Ubiquitin LigaseUNIV YALE·Filed 2024·Application pending·0 cites
- 2473US8507498B24, 6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinasesWABNITZ PHILIPP·Filed 2008·Granted Aug 13, 2013·4 cites·24 claims
- 2572US10946025B2CompoundsGLAXO GROUP LTD·Filed 2020·Granted Mar 16, 2021·0 cites·6 claims
- 2672US8524751B24-oxadiazol-2-YL-indazoles as inhibitors of P13 kinasesHAMBLIN JULIE NICOLE·Filed 2010·Granted Sep 3, 2013·3 cites·9 claims
- 2769US8765743B2CompoundsBALDWIN IAN ROBERT·Filed 2009·Granted Jul 1, 2014·1 cites·10 claims
- 2869US2018325911A1Novel compoundsGLAXO GROUP LTD·Filed 2018·Application pending·0 cites
- 2967US2014080830A1Novel CompoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2013·Application pending·0 cites
- 3066US2017157136A1Novel compoundsGLAXO GROUP LTD·Filed 2017·Application pending·0 cites
- 3164US2017015656A1Novel compoundsGLAXO GROUP LTD·Filed 2016·Application pending·0 cites
- 3261US2015328226A1Novel CompoundsGLAXO GROUP LTD·Filed 2015·Application pending·0 cites
- 3356US2017081278A1Novel compoundsGLAXO GROUP LTD·Filed 2016·Application pending·0 cites
- 3456US2016237073A1Novel Polymorphs and SaltsGLAXO GROUP LTD·Filed 2016·Application pending·0 cites
- 3554US2019127359A1Compounds & Methods for the Enhanced Degradation of Targeted Proteins & Other Polypeptides by an E3 Ubiquitin LigaseUNIV YALE·Filed 2018·Application pending·0 cites
- 3650US8658635B2Benzpyrazol derivatives as inhibitors of PI3 kinasesBALDWIN IAN ROBERT·Filed 2009·Granted Feb 25, 2014·0 cites·11 claims
- 3744US2016257664A1Novel compoundsGLAXOSMITHKLINE LLC·Filed 2014·Application pending·0 cites
- 3843US2016304478A1Novel compoundsGLAXO GROUP LTD·Filed 2016·Application pending·0 cites
- 3943US2013338147A14,6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinasesINGENIUM PHARMACEUTICALS GMBH·Filed 2013·Application pending·0 cites
- 4042US2009136448A1Antiviral 2-Carboxy-Thiophene CompoundsCORFIELD JOHN ANDREW·Filed 2006·Application pending·0 cites
- 4136US2021238162A1Chemical compoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Application pending·0 cites
- 4235US2012245171A1Benzpyrazole derivatives as inhibitors of pi3 kinasesBALDWIN IAN ROBERT·Filed 2010·Application pending·0 cites
- 4335US2012238559A1Novel compoundsBALDWIN IAN ROBERT·Filed 2010·Application pending·0 cites
- 4435US2012238571A1Indazole derivatives as pi 3-kinaseBALDWIN IAN ROBERT·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →